You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

12 Results
Guidelines and Advice
Status: Archived
ID: 6-22
Jan 2007
Guidelines and Advice
Status: Archived
ID: CED 4
May 2007
Guidelines and Advice
Status: Archived
ID: CED 6
Jun 2007
Guidelines and Advice
Status: In-Review
ID: 7-14
Version: 3
Dec 2018
Guidelines and Advice
Status: Archived
ID: 6-19
Jan 2007
Guidelines and Advice
Status: Archived
ID: 7-1-2N
Dec 2007
Guidelines and Advice
Status: Archived
ID: CED 5
May 2007
Guidelines and Advice
Status: Archived
ID: 4-14
Oct 2007
Cancer facts
Dec 2018
Guidelines and Advice
Status: Archived
ID: DAP
Jun 2007
Regimen
Cancer Type:
Breast
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Drugs Used:
CARBOplatin,
gemcitabine
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Dec 2018
Regimen
Cancer Type:
Hematologic, 
Lymphoma - Non-Hodgkin's Low Grade
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Funding:
New Drug Funding Program
    Obinutuzumab - In Combination with Chemotherapy for Refractory Follicular Lymphoma
ODB - General Benefit
    chlorambucil
Show More Show more tags
, Show Less Show fewer tags
Drugs Used:
oBINutuzumab,
chlorambucil
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Dec 2018